Search Within

Craig Steven Sauter

Formats
  1. Meeting Abstract (203)
  2. Journal Article (113)
  3. Research Letter (7)
  4. Review (5)
  5. Guidelines (3)
  6. Book Section (2)
  7. Editorial (1)
Groups
  1. Bone Marrow Transplant (334)
  2. Center for Hematologic Malignancies (334)
  3. Department of Medicine (334)
  4. Hematologic Malignancies, Division of (334)
  5. Survivorship Research (233)
  6. CTCR Scholars (204)

More Groups

People
  1. Miguel-Angel Perales (195)
  2. Sergio Giralt (192)
  3. Parastoo Dahi (135)
  4. Sean Devlin (127)
  5. Esperanza Papadopoulos (101)
  6. Juliet Barker (94)

More People

Years
  1. 2024 (1)
  2. 2023 (14)
  3. 2022 (32)
  4. 2021 (36)
  5. 2020 (42)
  6. 2019 (41)

More Years

Publications
  1. Blood (102)
  2. Biology of Blood and Marrow Transplantation (80)
  3. Bone Marrow Transplantation (25)
  4. Transplantation and Cellular Therapy (20)
  5. Blood Advances (18)
  6. Journal of Clinical Oncology (13)

More Publications

Publishers
  1. American Society of Hematology (120)
  2. Elsevier Inc. (106)
  3. Nature Publishing Group (34)
  4. American Society of Clinical Oncology (13)
  5. Wiley Blackwell (10)
  6. Taylor & Francis Group (9)

More Publishers

Results (334)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dermatologic adverse events following CD19-directed CAR T-cell therapy in hematologic malignancies
    Meeting Abstract

    Storgard, R.; Reingold, R.; Parisi, R.; Dusza, S.; Noor, S.; Park, J.; Sauter, C.; Curran, K.; Perales, M.; Scordo, M.; more...
    Journal of the American Academy of Dermatology (2024)

    Fulltext@MSK | Save
  • Pilot study of longitudinal geriatric assessment and neurocognitive evaluation in CAR T-cell therapy for older patients with relapsed refractory, large B-cell lymphoma
    Meeting Abstract

    Lin, R. J.; Kim, S. J.; Correa, D.; Elko, T. A.; Lobaugh, S.; Baser, R.; Koch, A.; Hanley, D. M.; Palomba, M. L.; Dahi, P. B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase II trial of prophylactic anakinra to prevent neurotoxicity in patients receiving anti-CD19 CAR T-cell therapy for relapsed or refractory lymphoma: Final results from cohort 2
    Meeting Abstract

    Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G. L.; Dahi, P. B.; Lin, R. J.; Scordo, M.; Perales, M. A.; Leslie, L. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Subgroup analyses of primary refractory vs early relapsed large B-cell lymphoma (LBCL) from the TRANSFORM study of lisocabtagene maraleucel (liso-cel) vs standard of care (SOC) as second-line (2L) therapy
    Meeting Abstract

    Glass, B.; Nastoupil, L.; Kamdar, M.; Chavez, J. C.; Ghesquieres, H.; Ghosh, M.; Holmes, H.; López-Guillermo, A.; Martínez-López, J.; Novak, U.; more...
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • Subgroup analyses of primary refractory (refr) vs early relapsed (rel) large B-cell lymphoma (LBCL) from the TRANSFORM study of lisocabtagene maraleucel (liso-cel) vs standard of care (SOC) as second-line (2L) therapy
    Meeting Abstract

    Nastoupil, L. J.; Kamdar, M. K.; Chavez, J. C.; Ghesquieres, H.; Ghosh, M.; Holmes, H.; López Guillermo, A.; Martinez-Lopez, J.; Novak, U.; Ribrag, V.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma
    Research Letter

    Lin, R. J.; Kim, S. J.; Brown, S.; Elko, T. A.; Ruiz, J. D.; Hanley, D. M.; Palomba, M. L.; Perales, M. A.; Shah, G. L.; Dahi, P. B.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma
    Journal Article

    Merrill, M. H.; Dahi, P. B.; Redd, R. A.; McDonough, M. M.; Chen, Y. B.; DeFilipp, Z.; Herrera, A. F.; Fisher, D. C.; LaCasce, A. S.; Odejide, O. O.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: Phase 2 trial interim results
    Journal Article

    Park, J. H.; Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G.; Dahi, P.; Lin, R. J.; Scordo, M.; Perales, M. A.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Lisocabtagene maraleucel (LISO‐CEL) versus standard of care (SOC) as second‐line therapy in large B‐cell lymphoma (TRANSFORM study): Subgroup analyses by prior therapy response
    Meeting Abstract

    Nastoupil, L. J.; Kamdar, M.; Chavez, J. C.; Ghesquieres, H.; Ghosh, M.; Holmes, H.; López‐Guillermo, A.; Martínez‐López, J.; Novak, U.; Ribrag, V.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma
    Journal Article

    Zurko, J.; Ramdial, J.; Shadman, M.; Ahmed, S.; Szabo, A.; Iovino, L.; Tomas, A. A.; Sauter, C.; Perales, M. A.; Shah, N. N.; more...
    Haematologica (2023)

    Fulltext@MSK | Save